Glutamic acid reverses Pb2+-induced reductions of NMDA receptor subunits in vitro

NeuroToxicology

Volumn 27, Issue 2, 2006, Pages 169-175

  Xu, Shang Zhi ^a   Rajanna, Bettaiya ^a  

^a ALCORN STATE UNIVERSITY   (United States)

Author keywords

GA; MK 801; Neuron; NMDA receptor; Pb2+

Indexed keywords

AGAROSE; DIZOCILPINE; GLUTAMIC ACID; LEAD; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PROTEIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CELL FREE SYSTEM; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; EXPOSURE; FEMALE; FETUS; HYPOTHESIS; IMMUNOPRECIPITATION; IN VITRO STUDY; LEAD POISONING; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; RAT STRAIN; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; IMMUNOPRECIPITATION; LEAD; NERVE TISSUE PROTEINS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA;

EID: 32244437784     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2005.08.005     Document Type: Article

References (46)

1. M.R. Basha, W. Wei, M. Brydie, M. Razmiafshari, and N.H. Zawia Lead-induced developmental perturbations in hippocampal Sp1 DNA-binding are prevented by zinc supplementation: in vivo evidence for Pb and Zn competition Int J Dev Neurosci 21 2003 1 12
2. R.L. Canfield, M.H. Gendle, and D.A. Cory-Slechta Impaired neuropsychological functioning in lead-exposed children Dev Neuropsychol 26 2004 513 540
3. CDC-MMWR, May 27, 2005. Blood lead levels - United states, 1999-2002. 54(20), 513-516.
4. L.R.F. Faro, J.L.M. Do Nascimento, M. Alfonso, and R. Duran Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors Neuropharmacology 42 2002 612 618
5. P. Gavazzo, A. Gazzoli, M. Mazzolini, and C. Marchetti Lead inhibition of NMDA channels in native and recombinant receptors NeuroReport 12 2001 3121 3125
6. 2+-exposed rats: implications for synaptic targeting and cell surface expression of NMDAR complexes Brain Res Mol Brain Res 113 2003 37 43
7. T.R. Guilarte, C.D. Toscano, J.L. McGlothan, and S.A. Weaver Enviromental enrichment reverses cognitive and molecular deficits induced by developmental lead exposure Ann Neurol 53 2002 50 56
8. F. Huang, and J.S. Schneider Effects of lead exposure on proliferation and differentiation of neural stem cells derived from different regions of embryonic rat brain Neurotoxicology 25 2004 1001 1012
9. C. Ikonomidou, F. Bosch, M. Miksa, P. Bittigau, J. Vockler, and K. Dikranian Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain Science 283 1999 70 74
10. C. Ikonomidou, V. Stefovska, and L. Turski Neuronal death enhanced by N-methyl-d-aspartate antagonists Proc Natl Acad Sci USA 97 2000 12885 12890
11. K. Ishihara, M. Alkondon, J.G. Montes, and E.X. Albuquerque Ontogenically related properties of N-methyl-d-aspartate receptors in rat hippocampal neurons and the age-specific sensitivity of developing neurons to lead J Pharmacol Exp Ther 273 1995 1459 1470
12. J.F.W. Keana, R.N. McBurney, M.W. Scherz, J.B. Fischer, P.N. Hamilton, and S.M. Smith Synthesis and characterization of a series of diarylguanidines that are non-competitive N-methyl-d-aspartate receptor antagonists with neuroprotective properties Proc Natl Acad Sci USA 86 1989 5631 5635
13. R. Kim, H. Hu, A. Rotnitzky, D. Bellinger, and H. Needleman A longitudinal study of chronic lead exposure and physical growth in Boston children Environ Health Perspect 103 1995 952 957
14. W.K. Lau, C.W. Yeung, P.W. Lui, L.H. Cheung, N.T. Poon, and K.K.L. Yung Different trends in modulation of NMDAR1 and NMDAR2B gene expression in cultured cortical and hippocampal neurons after lead exposure Brain Res 932 2002 10 24
15. M.A.S. Laidlaw, H.W. Mielke, G.M. Filippelli, D.L. Johnson, and C.R. Gonzales Seasonality and children's blood lead levels: Developing a protective model using climatic variables and blood lead data from Indianapolis, Indiana, Syracuse, New York and New Orleans Louisiana (USA) Environ Health Perspect 113 2005 793 800
16. W.W. Lin, C.W. Wang, and D.M. Chuang Effects of depolarization and NMDA antagonists on the survival cerebella granule cells: a pivotal role for protein kinase C isoforms J Neurochem 68 1997 2577 2586
17. L.D. Liu, T.P. Wong, M.F. Pozza, K. Lingenhoehl, Y. Wang, and M. Sheng Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity Science 304 2004 1021 1024
18. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J Biol Chem 193 1951 265
19. C. Marchetti Molecular targets of lead in brain neurotoxicity Neurotoxicity Res 5 2003 221 236
20. 2+ permeation in rat cerebellar granule neurones J Neurochem 79 2001 407 416
21. P.T. McCauley, R.J. Bull, A.P. Tonti, S.D. Lutkenhoff, M.V. Meister, and J. Doerge The effect of prenatal and postnatal lead exposure on neonatal synaptogenesis in rat cerebral cortex J Toxicol Environ Health 10 1982 639 651
22. K.W. Muir, and K.R. Lees A randomised, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke Ann N Y Acad Sci 765 1995 315 316
23. S. Nakanishi, Y. Nakajima, M. Masu, Y. Ueda, K. Nakahara, and D. Watanabe Glutamate receptors: brain function and signal transduction Brain Res Brain Res Rev 26 1998 230 235
24. 2+ during development. Brain Res Mol Brain Res 66 1999 42 49
25. 2+: association with deficits of LTP and spatial learning Neurotoxicology 22 2001 635 643
26. M.K. Nihei, N.L. Desmond, J.L. McGlothan, A.C. Kuhlmann, and T.R. Guilarte N-Methyl-d-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning Neuroscience 99 2000 233 242
27. K. Ogita, H. Okuda, Y. Yamamoto, N. Nishiyama, and Y. Yoneda In vivo neuroprotective role of NMDA receptors against kainite-induced excitotoxicity in murine hippocampal pyramidal neurons J Neurochem 85 2003 1336 1346
28. I.A. Omelchenko, C.S. Nelson, and C.N. Allen Lead inhibition of N-methyl-d-aspartate receptors containing NR2A, NR2C and NR 2D subunits J Pharmacol Exp Ther 282 1997 1458 1464
29. I. Perez-Otano, and M. Ehlers Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses Neurosignals 13 2004 175 189
30. J.P. Pin, and R. Duvoisin The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1995 1 26
31. B. Rajanna, S. Rajanna, E. Hall, and P.R. Yallapragada In vitro metal inhibition of N-methyl-d-aspartate specific glutamate receptor binding in neuronatal and adult rat brain Drug Chem Toxicol 20 1997 21 29
32. C.M. Regan Lead-impaired neurodevelopment: mechanisms and threshold values in the rodent Neurotoxicol Teratol 11 1989 533 537
33. C.M. Regan Neural cell adhesion molecules, neuronal development and lead toxicity Neurotoxicology 14 1993 69 74
34. J.S. Schneider, M.H. Lee, D.W. Anderson, L. Zuck, and T.I. Lidsky Enriched environment during development is protective against lead-induced neurotoxicity Brain Res 896 2001 48 55
35. R. Shukla, R.L. Bornschein, K.N. Dietrich, C.R. Buncher, O.G. Berger, and P.B. Hammond Fetal and infant lead exposure: effects on growth in stature Paediatrics 84 1989 604 612
36. A. Schurr Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels Curr Drug Targets 5 2004 603 618
37. N. Sizemore, S. Leung, and G.R. Stark Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit Mol Cell Biol 19 1999 4798 4805
38. L. Struzynska, and G. Sulkowski Relationship between glutamine, glutamate, and GABA in nerve endings under Pb-toxicity conditions J Inorg Biochem 98 2004 951 958
39. J.B. Suszkiw Presynaptic disruption of transmitter release by lead Neurotoxicology 25 2004 599 604
40. K.K. Tai, S.E. Blondelle, J.M. Ostresh, R.A. Houghten, and M. Montal An N-methyl-d-aspartate receptor channel blocker with neuroprotective activity Proc Natl Acad Sci USA 98 2000 3519 3524
41. 2+ exposure alters NMDAR subtypes and reduces CREB phosphorylation in the rat brain Dev Brain Res 139 2002 217 226
42. R. Tremblay, K. Hewitt, H. Lesiuk, G. Mealing, P. Morley, and J.P. Durkin Evidence that brain-derived neurotrophic factor neuroprotection is linked to its ability to reverse the NMDA-induced inactivation of protein kinase C in cortical neurons J Neurochem 72 1999 102 111
43. H. Ujihara, and E.X. Albuquerque Developmental changes of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons J Pharmacol Exp Ther 263 1992 868 875
44. K.A. Waters, and R. Machaalani NMDA receptors in the developing brain and effects of noxious insults Neurosignals 13 2004 162 174
45. E.H.F. Wong, J.A. Kemp, T. Priestley, A.R. Knight, G.N. Woodruff, and L.L. Iversen The anticonvulsant MK801 is a potent N-methyl-d-aspartate antagonist Proc Natl Acad Sci USA 83 1986 7104 7108
46. N.H. Zawia, R. Sharan, M. Byrdie, T. Oyama, and T. Crumpton Sp1 as a target site for metal-induced perturbations of transcriptional regulation of developmental brain gene expression Dev Brain Res 107 1998 291 298